Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence

Human Pathology

Volumn 45, Issue 3, 2014, Pages 504-512

  Ortiz Martínez, Fernando ^a   Perez Balaguer, Ariadna ^a   Ciprián, Daniel ^a   Andrés, Leire ^b   Ponce, José ^a   Adrover, Encarna ^a   Sánchez Payá, José ^a   Aranda, Francisco I ^a   Lerma, Enrique ^c   Peiró, Gloria ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Breast carcinoma; Immunophenotype; mRNA; Osteopontin; qRT PCR

Indexed keywords

BREAST CARCINOMA; IMMUNOPHENOTYPE; MRNA; OSTEOPONTIN; QRT-PCR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOPONTIN; PROGNOSIS; RECEPTOR, ERBB-2; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894071187     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.10.015     Document Type: Conference Paper

References (34)

1. R. Siegel, C. DeSantis, and K. Virgo et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 2012 220 241
2. T. Sorlie, R. Tibshirani, and J. Parker et al. Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423
3. L.R. Rodrigues, J.A. Teixeira, and F.L. Schmitt et al. The role of osteopontin in tumor progression and metastasis in breast cancer Cancer Epidemiol Biomarkers Prev 16 2007 1087 1097
4. A.C. Cook, A.B. Tuck, and S. McCarthy et al. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression Mol Carcinog 43 2005 225 236
5. K. Koro, S. Parkin, and B. Pohorelic et al. Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration Breast Cancer Res Treat 126 2011 73 83
6. G.F. Weber, G.S. Lett, and N.C. Haubein Osteopontin is a marker for cancer aggressiveness and patient survival Br J Cancer 103 2010 861 869
7. M. Mirza, E. Shaughnessy, and J.K. Hurley et al. Osteopontin-c is a selective marker of breast cancer Int J Cancer 122 2008 889 897
8. B. He, M. Mirza, and G.F. Weber An osteopontin splice variant induces anchorage independence in human breast cancer cells Oncogene 25 2006 2192 2202
9. N. Patani, F. Jouhra, and W. Jiang et al. Osteopontin expression profiles predict pathological and clinical outcome in breast cancer Anticancer Res 28 2008 4105 4110
10. A.B. Tuck, F.P. O'Malley, and H. Singhal et al. Osteopontin expression in a group of lymph node negative breast cancer patients Int J Cancer 79 1998 502 508
11. P.S. Rudland, A. Platt-Higgins, and M. El-Tanani et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res 62 2002 3417 3427
12. Rudland S. de Silva, L. Martin, and C. Roshanlall et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer Clin Cancer Res 12 2006 1192 1200
13. M.H. Galea, R.W. Blamey, and C.E. Elston et al. The Nottingham Prognostic Index in primary breast cancer Breast Cancer Res Treat 22 1992 207 219
14. L.M. McShane, D.G. Altman, and W. Sauerbrei et al. REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 2006 229 235
15. R.M. Neve, K. Chin, and J. Fridlyand et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
16. S. Cappia, L. Righi, and D. Mirabelli et al. Prognostic role of osteopontin expression in malignant pleural mesothelioma Am J Clin Pathol 130 2008 58 64
17. G. Peiro, E. Adrover, and L. Sanchez-Tejada et al. Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma Mod Pathol 24 2011 201 208
18. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
19. M.C. Cheang, S.K. Chia, and D. Voduc et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 2009 736 750
20. V.H. Bramwell, G.S. Doig, and A.B. Tuck et al. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer Clin Cancer Res 12 2006 3337 3343
21. A.L. Bane, D. Pinnaduwage, and S. Colby et al. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors Breast Cancer Res Treat 117 2009 183 191
22. M. Ihnen, R.M. Wirtz, and K.T. Kalogeras et al. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer Br J Cancer 103 2010 1048 1056
23. M.M. Reinholz, S.J. Iturria, and J.N. Ingle et al. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR Breast Cancer Res Treat 74 2002 255 269
24. A. Prat, J.S. Parker, and O. Karginova et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res 12 2010 R68
25. Y.W. Kim, Y.K. Park, and J. Lee et al. Expression of osteopontin and osteonectin in breast cancer J Korean Med Sci 13 1998 652 657
26. A. Ribeiro-Silva, and J.P. Oliveira da Costa Osteopontin expression according to molecular profile of invasive breast cancer: a clinicopathological and immunohistochemical study Int J Biol Markers 23 2008 154 160
27. X. Wang, L. Chao, and G. Ma et al. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression Radiology 254 2010 69 78
28. J. Wang-Rodriguez, V. Urquidi, and A. Rivard et al. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status Breast Cancer Res 5 2003 R136 R143
29. X. Wang, L. Chao, and G. Ma et al. Increased expression of osteopontin in patients with triple-negative breast cancer Eur J Clin Invest 38 2008 438 446
30. M. Martin, E. Mahillo, and A. Llombart-Cussac et al. The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in Spain Clin Transl Oncol 8 2006 508 518
31. J.S. Parker, M. Mullins, and M.C. Cheang et al. Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167
32. L.A. Shevde, S. Das, and D.W. Clark et al. Osteopontin: an effector and an effect of tumor metastasis Curr Mol Med 10 2010 71 81
33. J. Dai, L. Peng, and K. Fan et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells Oncogene 28 2009 3412 3422
34. H. Shen, and G.F. Weber The osteopontin-c splice junction is important for anchorage-independent growth Mol Carcinog 2013 [Epub ahead of print].